Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

Zohreh Varasteh; Sarajo Mohanta; Stephanie Robu; Miriam Braeuer; Yuanfang Li; Negar Omidvari; Geoffrey Topping; Ting Sun; Stephan G. Nekolla; Antonia Richter; Christian Weber; Andreas Habenicht; Uwe A. Haberkorn; Wolfgang A. Weber

doi:10.2967/jnumed.119.226993

Research ArticleCardiology

Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn and Wolfgang A. Weber

Journal of Nuclear Medicine December 2019, 60 (12) 1743-1749; DOI: https://doi.org/10.2967/jnumed.119.226993

Zohreh Varasteh

1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sarajo Mohanta

2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany

3German Centre for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephanie Robu

1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Miriam Braeuer

1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yuanfang Li

2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Negar Omidvari

1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Geoffrey Topping

1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ting Sun

2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephan G. Nekolla

1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Antonia Richter

1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christian Weber

2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany

3German Centre for Cardiovascular Research, Munich Heart Alliance, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas Habenicht

2Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Uwe A. Haberkorn

4Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang A. Weber

1Department of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue 12

December 1, 2019

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

Journal of Nuclear Medicine Dec 2019, 60 (12) 1743-1749; DOI: 10.2967/jnumed.119.226993

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

Journal of Nuclear Medicine Dec 2019, 60 (12) 1743-1749; DOI: 10.2967/jnumed.119.226993

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
The Latest Developments in Imaging of Fibroblast Activation Protein
FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
Targeted PET Imaging of Chemokine Receptor 2-Positive Monocytes and Macrophages in the Injured Heart
Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
The Future of Nuclear Medicine Depends on the Quality of Its Research: Researchers at the University of Heidelberg Receive the Award for Best Article of the Year
The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
CARTing Away Cardiac Fibrosis
FAP: The Next Billion Dollar Nuclear Theranostics Target?

Google Scholar

Cardiology

Time from Tc-99m Sestamibi Injection to Imaging Scan for Rest and Stress Myocardial Perfusion Imaging
Use of Conventional Late Imaging Protocol for Dynamic SPECT Imaging
Evaluating the Effect of Performing Adjunct Low-Level Exercise During Injection of Regadenoson

Show more Cardiology

Basic

Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression

Show more Basic

Keywords

myocardial infarction
cardiac remodeling
fibroblast activation protein
molecular imaging
PET

Main menu

User menu

Search

Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Cardiology

Basic

Similar Articles

Keywords